JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

36.48 -0.92

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

36.3

Max

36.63

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	11.786 90.422
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+19.8% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	464M 2.2B
Eelmine avamishind	37.4
Eelmine sulgemishind	36.48

Uudiste sentiment

By Acuity

38%

62%

92 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. veebr 2026, 23:59 UTC

Market Talk

Oil Prices Fall Amid Signs of U.S.-Iran Negotiations -- Market Talk

1. veebr 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

1. veebr 2026, 23:44 UTC

Market Talk

Gold Falls as Markets Further Price in Warsh-Led Fed -- Market Talk

1. veebr 2026, 12:47 UTC

Omandamised, ülevõtmised, äriostud

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion -- Update

1. veebr 2026, 03:02 UTC

Omandamised, ülevõtmised, äriostud

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion

1. veebr 2026, 03:01 UTC

Omandamised, ülevõtmised, äriostud

KKR Consortium Currently Owns Near 20% Stake in STT GDC

1. veebr 2026, 03:01 UTC

Omandamised, ülevõtmised, äriostud

KKR Consortium Acquiring Remaining Stake in STT GDC With Singtel, Sources Say

31. jaan 2026, 18:48 UTC

Omandamised, ülevõtmised, äriostud

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- Update

31. jaan 2026, 16:40 UTC

Tulu

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

31. jaan 2026, 09:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30. jaan 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30. jaan 2026, 23:41 UTC

Market Talk

Deckers Outdoor Seen as Undervalued -- Market Talk

30. jaan 2026, 23:12 UTC

Omandamised, ülevõtmised, äriostud

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30. jaan 2026, 22:20 UTC

Tulu

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30. jaan 2026, 22:10 UTC

Market Talk

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30. jaan 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

30. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. jaan 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

30. jaan 2026, 21:42 UTC

Tulu

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30. jaan 2026, 21:36 UTC

Tulu

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30. jaan 2026, 21:33 UTC

Tulu

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30. jaan 2026, 20:42 UTC

Tulu

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30. jaan 2026, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

19.8% tõus

12 kuu keskmine prognoos

Keskmine 43.75 USD 19.8%

Kõrge 55 USD

Madal 32 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

92 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.